Reduction in Gastrointestinal Cancers in Cirrhotic Patients Receiving Rifaximin vs Lactulose Only Therapy for Hepatic Encephalopathy

Background Rifaximin and/or lactulose therapy is widely used in cirrhotic patients for the prevention and treatment of hepatic encephalopathy. The incidence of gastrointestinal cancers in these patients on lactulose, rifaximin, and/or combination therapy is unknown. We investigated the possible effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Ankoor H, Li, You, Minacapelli, Carlos D, Catalano, Kaitlyn, Rustgi, Vinod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039763/
https://www.ncbi.nlm.nih.gov/pubmed/36974238
http://dx.doi.org/10.7759/cureus.35259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039763/
https://www.ncbi.nlm.nih.gov/pubmed/36974238
http://dx.doi.org/10.7759/cureus.35259

Ejemplares similares